The Nanomedicine Lab aims to generate and disseminate fundamental knowledge in the field of nanomedicine by bringing together nanotechnology, bioengineering, pharmacology and their translation to advanced, clinically-relevant therapeutics and diagnostics.

Our mission is to pioneer the cutting-edge and emerging discipline of nanomedicine by bringing advanced materials and nanoscale platforms to the clinic.

The main lines of research in Nanomedicine Lab include:

- Nanomaterials as transport systems for therapeutic and diagnostic applications against cancer and neurodegenerative disease.
- Translation of advanced materials to the clinic.
- Discovery of novel liposome and vesicle systems to be used as components of therapeutics in oncology and neurology.
- Neurotechnology based on adaptable, thin-film technologies for therapeutic applications in oncology and neurology.

The Nanomedicine Lab has been awarded one of the prestigious ERC Synergy Grants titled SKIN2DTRONICS.

📌 Research Support Technician - Nanomedicine Research Group (Bellaterra)
🏢 Institut Catala de Nanociencia i Nanotecnologia
📍 Bellaterra